Across TCGA pan-cancer cohorts, RPL12P44 RNA differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of RPL12P44’s most consistent transcriptional readouts.
The strongest signal is observed in pancreatic adenocarcinoma (PAAD), where RPL12P44 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RPL12P44 is over-expressed in tumor, although a few such as KIRC and KIRP show the opposite, repressed pattern.
PAAD, KIRC, and LIHC are the cancer types where RPL12P44 tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RPL12P44 RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.